ARCHIVES

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Mihich Recommendation for Antigen Development In BRMP Summarized

December 14, 1979

Guest Editorial by Robert Cook-Deegan: Myriad Case Ruling Likely to Concur With DOJ Arguments

April 19, 2013

In Brief: First CREG Announcement Due In Late April For In Vitro Carcinogen Test Improvements

March 21, 1975

In Brief: Columbia Still In Running As Comprehensive Center In ’78; Illinois Withdraws Application

June 24, 1977

NCCS Networker Volume 9 Issue 2, Summer 1995

June 13, 1995

President Requests Extra $200 Million For NIH

March 7, 2014